New shot shows promise against tough cancers

NCT ID NCT07213817

Recruiting now Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 4 times

Summary

This study tests a new drug called IPN60300 in adults with advanced solid tumors that have spread or not responded to standard treatments. The goal is to find the best dose and check if it is safe and shrinks tumors. All participants get the drug by injection, and the study involves regular blood tests and check-ups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm metastatic neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED SOLID TUMOR METASTATIC SOLID TUMOR

Contacts and locations

Locations

Centre Leon Berard
RECRUITING

Lyon, France
Gustave Roussy Cancer Campus Grand Paris- (Institut de Cancerologie Gustave-Roussy)
RECRUITING

Villejuif, France
Hospital Universitari Vall d'Hebron
NOT_YET_RECRUITING

Barcelona, Spain
Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene Gauducheau
RECRUITING

Saint-Herblain, France
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
NEXT Oncology
RECRUITING

San Antonio, Texas, 78229, United States
NEXT Oncology
RECRUITING

Fairfax, Virginia, 22031, United States
NEXT Quiron-Barcelona
NOT_YET_RECRUITING

Barcelona, Spain
START Madrid CIOCC Hospital Universitario HM Sanchinarro
NOT_YET_RECRUITING

Madrid, Spain
START Midwest
RECRUITING

Grand Rapids, Michigan, 49546, United States
Sidney Kimmel Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Yale Cancer Center-Yale University
RECRUITING

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.